指南与共识儿科与产科急症消化、代谢与肾脏急症

指南第403号:附件肿块的初步检查与管理

Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
指南 / 共识 · J Obstet Gynaecol Can · 2020-01-01
一句话结论加拿大妇产科医师学会指南:附件肿块患者应评估个人危险因素、病史和体格检查,并行影像学和实验室检查,以分流至妇科肿瘤医师或按指南404管理良性肿块。

该指南由加拿大妇产科医师学会制定,目标人群为18岁及以上因附件肿块接受评估的成年女性,适用对象包括急诊医学医师。指南建议对附件肿块患者评估个人危险因素、病史和体格检查,初始评估还应包括影像学和实验室检查,以将患者分流至妇科肿瘤医师进行进一步管理,或按照SOGC指南第404号对良性卵巢肿块进行初步检查和管理。指南采用GRADE方法对证据质量进行评级,共检索到2350项研究,纳入59项。卵巢癌结局在由妇科肿瘤医师进行初始手术时得到改善,可能是由于完整的 surgical staging 和最佳的肿瘤细胞减灭。

要点

  • 附件肿块患者应评估个人危险因素、病史和体格检查,作为初始评估的一部分。
  • 初始评估应包括影像学和实验室检查,以将患者分流至妇科肿瘤医师或按SOGC指南第404号管理良性肿块。
  • 卵巢癌结局在由妇科肿瘤医师进行初始手术时得到改善,可能由于完整的 surgical staging 和最佳肿瘤细胞减灭。
  • 指南适用于18岁及以上因附件肿块接受评估的成年女性,适用对象包括急诊医学医师。
  • 证据质量采用GRADE方法评级,共纳入59项研究。

适用人群与场景

  • 18岁及以上因附件肿块接受评估的成年女性。
  • 适用对象包括妇科医师、产科医师、家庭医师、普外科医师、急诊医学专家、放射科医师、超声技师、护士、医学生、住院医师和研究员。

处置流程与药物剂量

  • 附件肿块患者应评估个人危险因素、病史和体格检查。
  • 初始评估应包括影像学和实验室检查。
  • 根据评估结果将患者分流至妇科肿瘤医师进行管理,或按照SOGC指南第404号对良性卵巢肿块进行初步检查和管理。

研究设计与关键结果

  • 指南制定机构为加拿大妇产科医师学会,采用GRADE方法对证据质量进行评级。
  • 检索PubMed、Cochrane Wiley和Cochrane系统评价,检索时间为2018年1月,纳入2000年以来发表的英文人类研究,共检索到2350项研究,纳入59项。
  • 证据按质量降序选择:荟萃分析、系统评价、指南、随机对照试验、前瞻性队列研究、观察性研究、非系统评价、病例系列和报告。
  • 卵巢癌结局在由妇科肿瘤医师进行初始手术时得到改善,可能由于完整的 surgical staging 和最佳肿瘤细胞减灭。

证据类型、等级与局限

  • 证据类型:指南,采用GRADE方法评级。
  • 证据质量评级标准见在线附录A表A1,强推荐和弱推荐的解释见在线附录A表A2。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 急诊医学医师对附件肿块患者应评估个人危险因素、病史和体格检查,并安排影像学和实验室检查。
  • 根据评估结果,将患者分流至妇科肿瘤医师或按照SOGC指南第404号管理良性卵巢肿块。
  • 卵巢癌结局在由妇科肿瘤医师进行初始手术时得到改善,可能由于完整的 surgical staging 和最佳肿瘤细胞减灭。

指南或共识出处

  • 指南名称:Guideline No. 403: Initial Investigation and Management of Adnexal Masses;发布机构:Society of Obstetricians and Gynaecologists of Canada;年份:原文未明确写出。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To aid primary care physicians, emergency medicine physicians, and gynaecologists in the initial investigation of adnexal masses, defined as lumps that appear near the uterus or in or around ovaries, fallopian tubes, or surrounding connective tissue, and to outline recommendations for identifying women who would benefit from a referral to a gynaecologic oncologist for further management.

INTENDED USERS: Gynaecologists, obstetricians, family physicians, general surgeons, emergency medicine specialists, radiologists, sonographers, nurses, medical learners, residents, and fellows.

TARGET POPULATION: Adult women 18 years of age and older presenting for the evaluation of an adnexal mass.

OPTIONS: Women with adnexal masses should be assessed for personal risk factors, history, and physical findings. Initial evaluation should also include imaging and laboratory testing to triage women for management of their care either by a gynaecologic oncologist or as per SOGC guideline no. 404 on the initial investigation and management of benign ovarian masses.

EVIDENCE: A search of PubMed, Cochrane Wiley, and the Cochrane systematic reviews was conducted in January 2018 for English-language materials involving human subjects published since 2000 using three sets of terms: (i) ovarian cancer, ovarian carcinoma, adnexal disease, ovarian neoplasm, adnexal mass, fallopian tube disease, fallopian tube neoplasm, ovarian cyst, and ovarian tumour; (ii) the above terms in combination with predict neoplasm staging, follow-up, and staging; and (iii) the above two sets of terms in combination with ultrasound, tumour marker, CA 125, CEA, CA19-9, HE4, multivariable-index-assay, risk-of-ovarian-malignancy-algorithm, risk-of-malignancy-index, diagnostic imaging, CT, MRI, and PET. Relevant evidence was selected for inclusion in descending order of quality of evidence as follows: meta-analyses, systematic reviews, guidelines, randomized controlled trials, prospective cohort studies, observational studies, non-systematic reviews, case series, and reports. Additional articles were identified through cross-referencing the identified reviews. The total number of studies identified was 2350, with 59 being included in this review.

VALIDATION METHODS: The content and recommendations were drafted and agreed upon by the authors. The Executive and Board of the Society of Gynecologic Oncology of Canada reviewed the content and submitted comments for consideration. The Board of Directors of the Society of Obstetricians and Gynaecologists of Canada approved the final draft for publication. The quality of evidence was rated using the criteria described in the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methodology framework (Table A1 of Online Appendix A). See Table A2 of Online Appendix A for the interpretation of strong and weak recommendations. The summary of findings is available upon request.

BENEFITS, HARMS, COSTS: Adnexal masses are common, and guidelines on how to triage them and manage the care of patients presenting with adnexal masses will continue to guide the practice of primary care providers and gynaecologists. Ovarian cancer outcomes are improved when initial surgery is performed by a gynaecologic oncologist, likely as a result of complete surgical staging and optimal cytoreduction. Given these superior outcomes, guidelines to assist in the triage of adnexal masses and the referral and management of the care of patients with an adnexal mass are critical.

SUMMARY STATEMENTS (GRADE RATINGS IN PARENTHESES): RECOMMENDATIONS (GRADE RATINGS IN PARENTHESES).

来源:J Obstet Gynaecol Can,查看原文。版权归原作者所有。

参考来源

  1. Salvador S, Scott S, Glanc P, et al. Guideline No. 403: Initial Investigation and Management of Adnexal Masses. J Obstet Gynaecol Can. 2020. PMID: 32736853. doi:10.1016/j.jogc.2019.08.044

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。